Summary by Futu AI
The Securities and Exchange Commission (SEC) has declared that Processa Pharmaceuticals, Inc.'s Form S-3 is now effective as of May 28, 2024, at 4:30 PM. This form is typically used by companies to register securities for potential future offerings, indicating that Processa Pharmaceuticals may be preparing to issue new securities to investors. The effectiveness of the form marks a key regulatory step for the company in accessing capital markets.